fda glp-1 compounding crackdown september 2025 FDA proposes a new GLP-1

Always consult your provider to see which is best for your specific health history

S., Foller M

This is the number one question we get asked, so its important to be clear here: all of the GLP-1 agonist medications are intended for long-term, continuous use similar to medications used to manage other heart disease risk factors like hypertension or high cholesterol

Delta Sleep Inducing Peptide (DSIP): Reviewing the Research. BioLongevity Labs , 21 Oct

Blue Cross Blue Shield and other major insurers frequently require prior authorization before covering tirzepatide, a GLP-1 receptor agonist shown in clinical trials to reduce body weight by 20% or more